Oscar Health (NYSE:OSCR) Shares Down 3.6% - What's Next?

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shares traded down 3.6% during mid-day trading on Friday . The company traded as low as $16.18 and last traded at $16.19. 2,941,235 shares were traded during mid-day trading, a decline of 8% from the average session volume of 3,204,464 shares. The stock had previously closed at $16.80.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price for the company. Piper Sandler reaffirmed an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Oscar Health currently has an average rating of "Moderate Buy" and a consensus price target of $24.00.

Oscar Health Stock Down 2.7 %

The firm has a 50 day moving average price of $19.00 and a two-hundred day moving average price of $18.24. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same quarter in the prior year, the company earned ($0.07) EPS. The firm's revenue for the quarter was up 44.6% compared to the same quarter last year. As a group, research analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, CFO Richard Scott Blackley sold 68,978 shares of the company's stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the sale, the chief financial officer now owns 884,213 shares in the company, valued at $15,906,991.87. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 68,978 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the transaction, the chief financial officer now owns 884,213 shares in the company, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock worth $3,007,069 in the last 90 days. Corporate insiders own 25.11% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC bought a new position in Oscar Health in the first quarter worth approximately $4,117,000. Assenagon Asset Management S.A. raised its stake in shares of Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company's stock worth $32,368,000 after purchasing an additional 507,009 shares during the last quarter. Jupiter Asset Management Ltd. purchased a new stake in shares of Oscar Health in the first quarter worth approximately $653,000. Price T Rowe Associates Inc. MD raised its stake in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Oscar Health by 28.4% in the second quarter. The Manufacturers Life Insurance Company now owns 329,129 shares of the company's stock worth $5,207,000 after purchasing an additional 72,754 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.